I enjoyed the article "Judgment Day" in the December 1998 issue (page 2).
I have always believed the only reason PhyCor pretended to have an interest in a buyout of MedPartners was to expose the weak, overextended financial position of MedPartners.
J. Michael Condit, M.D.'s statement crediting MedPartners for "giving Kelsey-Seybold some financial discipline" is interesting. Apparently, he is confusing "financial discipline" with profits for the Birmingham, Ala., corporate office-regardless of the resulting damage to patient care.
Timothy Hebert, chief financial officer North Texas Anesthesia Consultants Dallas